New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation-Reference-Cited by-同舟云学术

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation

Published:2016-06 Issue:6 Volume:174 Page:1174-1178
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Coates L.C.¹²,Murphy R.³,Helliwell P.S.¹²⁴

Affiliation:

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds Leeds U.K.

2. Musculoskeletal Biomedical Research Unit Leeds Teaching Hospitals NHS Trust Leeds U.K.

3. Department of Dermatology Sheffield Teaching Hospitals and Sheffield Children's Hospital Sheffield U.K.

4. Bradford Teaching Hospitals NHS Foundation Trust Bradford U.K.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.14667

Reference8 articles.

1. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis: treatment recommendations for psoriatic arthritis;Coates LC;Arthritis Rheum,2016

2. Treatment recommendations for psoriatic arthritis

3. Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

4. National Institute for Health and Care Excellence.Psoriasis: assessment and management. NICE guidelines CG153. Available at:https://www.nice.org.uk/guidance/cg153(last accessed 1 April 2016).

5. National Institute for Health and Care Excellence.Apremilast for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance TA368. Available at:https://www.nice.org.uk/guidance/ta368(last accessed 1 April 2016).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating upadacitinib for the treatment of psoriatic arthritis;Expert Opinion on Pharmacotherapy;2022-01-11

2. Therapiestrategien der Psoriasisarthritis;Aktuelle Dermatologie;2021-12

3. Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis;Modern Rheumatology;2021-11-10

4. Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study;Annals of the Rheumatic Diseases;2021-05-13

5. Assessment of enthesitis in patients with psoriasis: Relationships with clinical features, screening questionnaries results, and quality of life: An ultrasound study;Vojnosanitetski pregled;2021